Press Release: Numerate : Numerate and Lundbeck Partner to Apply AI Drug Discovery to Unlock Challenges of Neuroscience Research

SAN FRANCISCO--(BUSINESS WIRE)--Numerate, Inc., a data-driven drug design company applying artificial intelligence (AI) to transform drug discovery, announced a multi-target research collaboration with Lundbeck Pharmaceutical to identify clinical candidates for the treatment of disorders in the central nervous system, including depression, psychosis, seizure and neurodegenerative disorders. "This is a drug discovery partnership that combines Lundbeck's deep understanding of drug discovery and d